Acurx Pharmaceuticals, Inc.
ACXP
$4.08
$0.225.70%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 12.58% | -20.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.61% | -22.74% | |||
| Operating Income | -5.61% | 22.74% | |||
| Income Before Tax | -4.52% | 22.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.52% | 22.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.52% | 22.74% | |||
| EBIT | -5.61% | 22.74% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 12.02% | 34.73% | |||
| Normalized Basic EPS | 12.02% | 34.72% | |||
| EPS Diluted | 12.02% | 34.73% | |||
| Normalized Diluted EPS | 12.02% | 34.72% | |||
| Average Basic Shares Outstanding | 18.80% | 18.36% | |||
| Average Diluted Shares Outstanding | 18.80% | 18.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||